The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates
about
Protection against Radiotherapy-Induced Toxicityγ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current StatusMedical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patentsUse of biomarkers for assessing radiation injury and efficacy of countermeasuresToll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axisA review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in larStrategies for designing synthetic immune agonists.Nonhuman primates as models for the discovery and development of radiation countermeasures.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.Pharmacological Modulation of Radiation Damage. Does It Exist a Chance for Other Substances than Hematopoietic Growth Factors and Cytokines?Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol.Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation.
P2860
Q26741273-659C38CE-4369-4A40-AD8C-577EB28E5BBCQ26751505-818CA904-A6B6-4DFE-8108-F1FF5B8362AEQ28817576-BF7CA43F-5AF9-4EF4-BAB7-B15AAEE6C5D2Q36519142-66FF338F-9B45-4E58-8A34-FF9F9CBFD3D6Q36607439-B314BFA8-F2C5-4770-910D-60673A8290E1Q38665691-25E1B1A0-96C5-4936-B69F-027790566F79Q38841677-1A05F884-0F15-4232-9A74-39F35743EB85Q39261890-0AD17AB4-CB01-41A4-ABBC-3B276F1FA6FDQ39398444-FF631AFB-67FC-46D7-B5F4-15BFA849D8F0Q39402305-F3DBDA1B-0E1F-4814-8610-8398158A36FDQ41992352-08BE3D83-0194-4451-A641-0B0F17AF7F9FQ48337702-17D7C41C-7CAE-4E95-94C9-27DC976F82F6Q50785469-B23F96A8-03D4-4A3E-9B88-908329F24D48
P2860
The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
The Toll-Like Receptor 5 Agoni ...... Syndrome in Non-Human Primates
@ast
The Toll-Like Receptor 5 Agoni ...... Syndrome in Non-Human Primates
@en
The Toll-Like Receptor 5 Agoni ...... Syndrome in Non-Human Primates
@nl
type
label
The Toll-Like Receptor 5 Agoni ...... Syndrome in Non-Human Primates
@ast
The Toll-Like Receptor 5 Agoni ...... Syndrome in Non-Human Primates
@en
The Toll-Like Receptor 5 Agoni ...... Syndrome in Non-Human Primates
@nl
prefLabel
The Toll-Like Receptor 5 Agoni ...... Syndrome in Non-Human Primates
@ast
The Toll-Like Receptor 5 Agoni ...... Syndrome in Non-Human Primates
@en
The Toll-Like Receptor 5 Agoni ...... Syndrome in Non-Human Primates
@nl
P2093
P2860
P3181
P1433
P1476
The Toll-Like Receptor 5 Agoni ...... Syndrome in Non-Human Primates
@en
P2093
Alexander N Shakhov
Anatoli S Gleiberman
Andrei A Purmal
Elena Feinstein
Ilia A Toshkov
Inna Shyshynova
Ivan Bespalov
Mark H Whitnall
Natalya V Narizhneva
Peter Krasnov
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0135388
P407
P577
2015-01-01T00:00:00Z